OpenAI Addresses Security Vulnerability in macOS App Certification Process 
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push 
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs 
Chinese Cars in Europe: Consumer Trust Is Shifting Fast 
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave 
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions 
Bill Ackman Eyes New Fund to Bet Against Market Complacency 
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs 
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028 
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles 
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion 
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth 
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
NEW YORK, June 13, 2017 -- In the campaign for cannabidiol (CBD) education, research, and science, Elixinol will bring two authorities on key health topics to the Cannabis World Congress and Business Expo (CWCBE) at the Javits Center June 14-16. The appearances and presentations will address the role of CBD in traumatic brain afflictions.
|
||||||||||
Photos accompanying this announcement are available at:
http://www.globenewswire.com/NewsRoom/AttachmentNg/24acb5c6-422a-4c80-a851-79a6b34d9f47
http://www.globenewswire.com/NewsRoom/AttachmentNg/22249652-86e7-411d-b88b-192634e0e999
| Leonard Marshall, 2X Super Bowl Champion for the NFL’s New York Giants. | |||
| WHEN: | Thursday June 15 from 1:30-5:30 p.m. | ||
| WHERE: | Javits Center | ||
| Cannabis World Congress & Business Expo (CWCBE) | |||
| Elixinol Booth (Tradeshow Floor) | |||
| WHAT: | Marshall will be available for interviews and autographs during this time. He will | ||
| be discussing his recent announcement to donate his brain to CTE research and | |||
| his use of CBD to manage his symptoms. Marshall was diagnosed with CTE as a | |||
| result of repeated traumatic brain concussions while playing professional football. | |||
| Retired Colonel (US Army) Phillip Blair, MD, PTSD and CBD Expert. | ||||||||||
| WHEN: | Thursday June 15, 10:00 a.m. | |||||||||
| PTSD & CBD: What You Need To Know | ||||||||||
| Friday June 16, 1:50 p.m. | ||||||||||
| Veterans Access Panel | ||||||||||
| WHERE: | Javits Center | |||||||||
| Cannabis World Congress & Business Expo (CWCBE) | ||||||||||
| WHAT: | During his military career, Dr. Blair provided care on three continents, including | |||||||||
| the Gulf War. Since retiring from the Army, in his private tele-medicine practice, | ||||||||||
| he has treated patients with a range of serious health conditions, including those | ||||||||||
| with PTSD, with cannabidiol (CBD) and become an in-demand expert on the | ||||||||||
| endocannabinoid system. He will be speaking on the effects of CBD for PTSD | ||||||||||
| victims based on his treatment system. | ||||||||||
| In-person interviews in New York for Dr. Blair may be scheduled from June 14- | ||||||||||
| 16. Phone interviews may be scheduled outside of these dates. | ||||||||||
CWCBE is open to the public. Press passes for CWCBE are available through the press office: http://www.cwcbexpo.com/press-registration-form-new-york/
About Elixinol:
Colorado-based Elixinol, founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most trusted CBD brand in the world. With a proven track record of growing and manufacturing high-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. Elixinol distributes CBD products globally in the United States, Japan, Puerto Rico, Brazil and the UK and Europe. More information available at Elixinol.com.
Media Contact: Chris Husong Elixinol +1 844-804-3504 ext 420 [email protected]
